承認 against Kmbaiorozikusu K.K.
KMバイオロジクス株式会社 (Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices)
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical DevicesMinistry of Health, Labour and WelfareAugust 2, 2022
Action summary
- Company
- Kmbaiorozikusu K.K.RomanizedOriginal: KMバイオロジクス株式会社Corporate Number: 6330001025098
- Governing law
- Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices薬機法
- Action type
- 承認承認
- Action date
- August 2, 2022
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
Violation
Machine-translated summary — verify against original
Approval was granted for the addition of efficacy for monkeypox prevention to the dry cell culture smallpox vaccine.
Show original Japanese text
乾燥細胞培養痘そうワクチンに対するサル痘の予防の効能追加について承認を行いました。
Source
Original Ministry of Health, Labour and Welfare announcement (in Japanese)The original Japanese disclosure is the authoritative record.
Watch this company
Get an email when Kmbaiorozikusu K.K. has new enforcement actions or registry changes (representative, address, business status). Sign-in is via a one-time email link — no password.
Language
日本語版を見る (Japanese)Company info
- English name
- Kmbaiorozikusu K.K. Romanized
- Japanese name
- KMバイオロジクス株式会社
- Corporate Number
- 6330001025098
- Registered address
- 熊本県熊本市北区大窪１丁目６番１号
About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.